EP3250563
Setin tríasól og aðferðir sem tengjast þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.1.2016EP published:
12.1.2022EP application number:
16703250.7
EP translation filed:
15.2.2022Grant published:
15.3.2022EPO information:
European Patent Register
Max expiry date:
28.1.2036Expiry date:
28.1.2027Next due date:
31.1.2027
Title in English:
SUBSTITUTED TRIAZOLES AND METHODS RELATING THERETOLanguage of the patent:
English
Timeline
Today
29.1.2016EP application
12.1.2022EP Publication
15.2.2022Translation submitted
15.3.2022Registration published
28.1.2027Expires
Owner
Name:
NEUROCRINE BIOSCIENCES, INC.Address:
6027 Edgewood Bend Court,, San Diego, CA 92130, US
Inventor
Name:
WILLIAMS, John, P.Address:
San Diego, California 92101, US
Name:
SLEE, DeborahAddress:
Cardiff, California 92007, US
Name:
MOORJANI, ManishaAddress:
San Diego, California 92127, US
Name:
ASHWEEK, Neil, J.Address:
Escondido, California 92027, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562110415 PDate:
30.1.2015Country:
US
Number:
201562259314 PDate:
24.11.2015Country:
US
Classification
Categories:
C07D 401/12, C07D 403/04, C07D 405/04, C07D 249/04, A61K 31/4192, A61K 31/422, A61K 31/497, A61K 31/5377, A61P 25/08, A61P 25/14
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 14.2.2022
Expires: 28.1.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 3.1.2023
Expires: 28.1.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 4.1.2024
Expires: 28.1.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.1.2025
Expires: 28.1.2026
Payer: Árnason Faktor ehf.
Number: 11
Paid: 20.1.2026
Expires: 28.1.2027
Payer: Árnason Faktor ehf.